ClinicalTrials.gg
CompletedNCT05055453Updated Jun 25, 2024Results posted

MyPhonak App Junior Pediatric Usability and Benefit Investigation

An interventional study of MyPhonak Junior App and Phonak Sky hearing aid in Hearing Loss, sponsored by Sonova AG. Completed at 1 site in Germany. Open to participants aged 7 Years to 17 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-06-25.

Sponsored by Sonova AG · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
16
Allocation
Not applicable
Ages
7 Years to 17 Years
Sex
All
01

Study summary

Participants age 8-17 with bilateral hearing loss will be fit with Phonak BTE (Behind-The-Ear) hearing aids and given access to the myPhonak Junior hearing app. The participants will use the app to adjust the hearing aid microphone and noise reduction settings.

02

Conditions studied

  • Hearing Loss

Browse trials for

03

In context

Hearing Loss

1,109 studies on the registry are indexed under Hearing Loss; 233 are open to participants now.

This study's enrollment of 16 is below the median of 40 across 778 interventional studies indexed under Hearing Loss.

Browse Hearing Loss studies →

Lead sponsor

Sonova AG is the lead sponsor of 88 studies on the registry; 6 are open to participants now.

Of its 27 completed or terminated interventional studies of FDA-regulated products, 19 (70%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children and adolescents between the ages of 7 and 17 years old.
  • bilateral mild to severe hearing loss
  • experienced hearing aid users for 6+ months

Exclusion criteria

Exclusion Criteria:

  • any additional disabilities to the hearing impairment
  • inability to complete the study procedures
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
16 participants (actual)

Study arms

  • Experimental
    Experimental Study Group

    Participants age 8-17 with bilateral hearing loss will be fit with Phonak BTE hearing aids and given access to the Phonak hearing app. The participants will use the app to adjust the hearing aid microphone and noise reduction settings.

    Device: MyPhonak Junior App · Device: Phonak Sky hearing aid

Interventions

  • DeviceMyPhonak Junior App

    The app is an accessory to the hearing aids which allows the user to make adjustments to their hearing aid in real-time. The hearing aid does not require the use of the app, but the objective of this study is to evaluate the effects of the user adjustments made via the app on the participant's speech intelligibility with the hearing aid.

  • DevicePhonak Sky hearing aid

    A Behind-The-Ear hearing aid (BTE) fit to hearing impaired persons with mild to severe hearing loss.

06

What researchers measure

Primary outcomes

  1. dB SNR (Decibel Signal to Noise Ratio) Score Using the OLSA (Oldenburg Sentence Test) Speech in Noise Test

    Target speech is presented from a speaker in front of participant while background noise is presented from 4 surrounding speakers. The level of noise is presented at 65 dB SPL (Sound Pressure Level),with target speech presented at variable levels, both louder and softer than the noise. The dB SNR is the level at which the participant can correctly repeat 50% of the words. A lower/negative dB SNR is better, indicating that 50% of the speech is understood when noise is louder than or close to the level of speech. This test was given in three, randomized conditions for each participant at two visits: 1) hearing aids in Automatic, 2) hearing aids in Automatic but Directionality and Noise Reduction customized by participant using the app (i.e. "preferred" settings), and 3) hearing aids in Automatic but with the Directionality set to lowest level 0, (i.e. omnidirectional), and Noise Reduction set to the highest level 10,or all the way on (i.e., "extreme").Results of both visits was averaged

    Time frame: Day 1 of study, repeated on Day 14 of study

Secondary outcomes

  1. Assessment of Hearing Situations in Children's Every Day Lives Questionnaire

    A German-language questionnaire which asks student to rate their listening quality in different environments. Participants compared their listening quality with hearing aids alone versus hearing aids plus the app. Rating scale is from 1 to 5 with 1 = mostly easy and 5 = mostly difficult, so a lower score is better, however a rating of 0 = no change. Participants were given one copy of questionnaire to fill out during week 1 of home trial, and a second copy to fill out during week 2 of home trial. Results are reported separately for week 1 and week 2.

    Time frame: Completion of first home trial at day 7, and completion of second home trial at day 14

07

Results

Posted Jun 25, 2024

Participant flow

Participant flow — Overall Study
MilestoneExperimental Study Group
Started16
Completed15
Not completed1

Outcome measures

PrimarydB SNR (Decibel Signal to Noise Ratio) Score Using the OLSA (Oldenburg Sentence Test) Speech in Noise Test

Target speech is presented from a speaker in front of participant while background noise is presented from 4 surrounding speakers. The level of noise is presented at 65 dB SPL (Sound Pressure Level),with target speech presented at variable levels, both louder and softer than the noise. The dB SNR is the level at which the participant can correctly repeat 50% of the words. A lower/negative dB SNR is better, indicating that 50% of the speech is understood when noise is louder than or close to the level of speech. This test was given in three, randomized conditions for each participant at two visits: 1) hearing aids in Automatic, 2) hearing aids in Automatic but Directionality and Noise Reduction customized by participant using the app (i.e. "preferred" settings), and 3) hearing aids in Automatic but with the Directionality set to lowest level 0, (i.e. omnidirectional), and Noise Reduction set to the highest level 10,or all the way on (i.e., "extreme").Results of both visits was averaged

Time frame:
Day 1 of study, repeated on Day 14 of study
Reported as:
Mean · dB
dB SNR (Decibel Signal to Noise Ratio) Score Using the OLSA (Oldenburg Sentence Test) Speech in Noise Test
dBExperimental Study Group
dB SNR for Automatic program, both visits averaged-1.33 ± 3.93
dB SNR for preferred settings of volume, NR, and Directionality, both visits averaged-2.83 ± 3.37
dB SNR for extreme setting, both visits averaged0.08 ± 4.15
Statistical analysis
  • Experimental Study Group · Durbin-Conover Pairwise Comparison · p = <0.001 (Result for comparison between automatic only and "preferred" app settings.)
  • Experimental Study Group · Durbin-Conover Pairwise Comparison · p = < 0.001 (Result of comparison between "preferred" app setting and "extreme" app setting)
  • Experimental Study Group · Durbin-Conover Pairwise Comparison · p = 0.002
SecondaryAssessment of Hearing Situations in Children's Every Day Lives Questionnaire

A German-language questionnaire which asks student to rate their listening quality in different environments. Participants compared their listening quality with hearing aids alone versus hearing aids plus the app. Rating scale is from 1 to 5 with 1 = mostly easy and 5 = mostly difficult, so a lower score is better, however a rating of 0 = no change. Participants were given one copy of questionnaire to fill out during week 1 of home trial, and a second copy to fill out during week 2 of home trial. Results are reported separately for week 1 and week 2.

Time frame:
Completion of first home trial at day 7, and completion of second home trial at day 14
Reported as:
Mean · score on a scale
Assessment of Hearing Situations in Children's Every Day Lives Questionnaire
score on a scaleExperimental Study Group
Rating of listening quality Hearing Aid only first home trial2.61 ± 1.36
Average rating of listening quality Hearing Aid with app adjustments first home trial1.88 ± 1.16
Rating of listening quality Hearing Aid only second home trial2.42 ± 1.54
Rating of listening quality Hearing Aid with app adjustments second home trial1.55 ± 1.05
Statistical analysis
  • Experimental Study Group · t-test, 2 sided · p = <0.001
  • Experimental Study Group · t-test, 2 sided · p = <.001

Adverse events

Collected over 9 weeks. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Experimental Study Group0/16 (0%)0/16 (0%)0/16 (0%)

Baseline characteristics

Age, Customized
Age, Customized(years)Experimental Study Group
Median12 (8 to 17)
Sex: Female, Male
Sex: Female, Male(Participants)Experimental Study Group
Female8
Male8
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Experimental Study Group
Region of Enrollment
Region of Enrollment(participants)Experimental Study Group
Germany16
08

Study locations

1 site
  • Universitätsmedizin Mainz, HNO-Klinik
    Mainz, Rhineland-Palatinate 55131, Germany
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Dec 1, 2023

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 25, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05055453
Lead sponsor
Sonova AG
Responsible party
Sponsor
First posted
Sep 24, 2021
Start date
Oct 4, 2021
Primary completion
Dec 8, 2022
Completion
Dec 8, 2022
Results posted
Jun 25, 2024
Last update
Jun 25, 2024

Study contacts

Anne K Läßig, M.D, M.D.
principal investigator · Johannes Gutenberg University Mainz

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion